A recent chapter titled “The Current Situation of Medicines Quality in Low- and Middle-Income Countries: New Challenges to be Addressed” (IntechOpen, 2025) sheds light on a growing global health concern: 10.5% of medicines worldwide are of poor quality, with the greatest impact seen in low- and middle-income countries. Harsh climates, weak regulatory systems, and fragmented supply ...





